A Prospective Phase II Study of Combined Androgen Blockade in Patients With Androgen Receptor-Positive Metastatic or Locally Advanced Unresectable Salivary Gland Carcinoma

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx771
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2018English

Androgen Receptor Signaling in Salivary Gland Cancer

Cancers
Cancer ResearchOncology
2017English

SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

Investigational New Drugs
OncologyPharmacology
2011English

Comparative Study Between Orchidectomy Alone and Orchidectomy With Hormonal Therapy (Combined Androgen Blockade) for Patients With Advanced Carcinoma of the Prostate

Basrah Journal of Surgery
2010English

Intermittent Versus Continuous Androgen Deprivation Therapy in Patients With Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND)

European Urology
Urology
2016English

Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma

Cancer
Cancer ResearchOncology
2019English

Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy